Puma Biotechnology, Inc.PBYINASDAQ
Loading
Year-over-year free cash flow growth rate
Latest
49.59%
↓ 84% vs avg
Percentile
P67
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
305.82%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 49.59% |
| Q3 2025 | -31.28% |
| Q2 2025 | 296.00% |
| Q1 2025 | -77.22% |
| Q4 2024 | 41.50% |
| Q3 2024 | 994.14% |
| Q2 2024 | -91.05% |
| Q1 2024 | 8.03% |
| Q4 2023 | -1.68% |
| Q3 2023 | 228.00% |
| Q2 2023 | 132.75% |
| Q1 2023 | -1543.19% |
| Q4 2022 | -96.04% |
| Q3 2022 | 224.40% |
| Q2 2022 | 48.41% |
| Q1 2022 | -394.85% |
| Q4 2021 | -151.77% |
| Q3 2021 | 14286.49% |
| Q2 2021 | -100.47% |
| Q1 2021 | 200.02% |
| Q4 2020 | -1016.21% |
| Q3 2020 | -89.46% |
| Q2 2020 | 240.52% |
| Q1 2020 | -1015.87% |
| Q4 2019 | 117.24% |
| Q3 2019 | -116.51% |
| Q2 2019 | 374.83% |
| Q1 2019 | -328.66% |
| Q4 2018 | 193.05% |
| Q3 2018 | 57.59% |
| Q2 2018 | -183.52% |
| Q1 2018 | 92.66% |
| Q4 2017 | -55.74% |
| Q3 2017 | -19.91% |
| Q2 2017 | -26.97% |
| Q1 2017 | 12.89% |
| Q4 2016 | -18.77% |
| Q3 2016 | 6.60% |
| Q2 2016 | -6.72% |
| Q1 2016 | -5.99% |